New York, NY -- (SBWIRE) -- 12/03/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Vringo, Inc (NASDAQ:VRNG), North American Oil & Gas Corp (OTCBB:NAMG), Achillion Pharmaceuticals, Inc (NASDAQ:ACHN), Alcoa Inc (NYSE:AA)
Vringo, Inc (NASDAQ:VRNG) showed a volume of 1.17 million shares by the end of last trade whereas the average volume of the stock remained 1.33 million shares. The stock opened the session at $3.13 but then moved to $3.25. At that price, the stock showed a negative performance of -1.88%. Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones. Vringo’s product consists of four components, such as The Vringo Mobile Application, The Vringo WAP Site, The Vringo Website and The Vringo Studio. Vringo (Israel) Ltd. is its wholly owned subsidiary. In July 2012, it merged with Innovate/Protect, Inc.
Will VRNG Get Buyers Even After The Recent Rally? Find Out Here
North American Oil & Gas Corp (OTCBB:NAMG) opened the session at $0.98 and closed the session at $1.02. The stock showed a positive performance of 6.69% in previous trading session. Traded with volume of 1.07 million shares in the prior session and the average volume of the stock remained 548,931.00 shares. North American Oil & Gas Corp. (NAMOG) is a development-stage company. The Company is engaged in oil and gas exploration in California, through its subsidiary Lani. The Company is focused on its oil and natural gas exploration, exploitation and development operations on projects located in the San Joaquin Basin, California; its Tejon Main prospect, Tejon Extension prospect, and White Wolf project. Lani drilled its exploratory well on the Tejon Ranch Extension on November 25, 2012. The Company completed drilling on Well 77-20 in December 2012.
For How Long NAMG will fight for Profitability? Read This Trend Analysis report
Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) opened the session at $3.55 and closed the session at $3.45. The stock showed a negative performance of -0.29% in previous trading session. Traded with volume of 3.12 million shares in the prior session and the average volume of the stock remained 2.25 million shares. The beta of the stock remained 0.54. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections. The Company focuses on the development of four drug candidates for the treatment of HCV: ACH-1625, a NS3 protease inhibitor for the treatment of HCV,
Why Should Investors Buy ACHN After the Recent Fall? Just Go Here and Find Out
Alcoa Inc (NYSE:AA) the stock decreased -0.62% and finished the session at $9.55. Traded with volume of 20.72 million shares in the prior session and the average volume of the stock remained 27.42 million shares. The beta of the stock remained 1.92. Alcoa Inc. (Alcoa) is engaged in the production and management of primary aluminum, fabricated aluminum, and alumina combined, through its participation in technology, mining, refining, smelting, fabricating, and recycling. Alcoa’s products are used worldwide in aircraft, automobiles, commercial transportation, packaging, building and construction, oil and gas, defense, consumer electronics, and industrial applications.
Will AA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)